Green Hygienics Holdings Inc. (GRYN) Recruits Former Johnson & Johnson Head of Regulatory & Medical Affairs, Italy, as New Chief Scientific Officer

Rhea-AI Summary

Green Hygienics Holdings Inc. (OTCQB: GRYN) has appointed Dr. Francesca Serraino Fiory as the new Chief Scientific Officer. She will head product development and R&D initiatives at the company's biotechnology subsidiary, TruLife Biotech, and manage partnerships with research institutions. Dr. Serraino Fiory has extensive experience in the pharmaceutical industry, having previously worked with Pfizer, Johnson & Johnson, and Perrigo Pharma, where she led regulatory affairs. Her appointment aims to drive sustainable growth and regulatory compliance in product offerings.

Positive

• Appointment of Dr. Francesca Serraino Fiory as Chief Scientific Officer.
• Dr. Serraino Fiory's extensive experience in regulatory and medical affairs.
• Focus on accelerating product development and R&D at TruLife Biotech.

Negative

• None.

SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company") has appointed Dr. Francesca Serraino Fiory as the Company’s new Chief Scientific Officer. Dr. Serraino Fiory will oversee product development, accelerating the Company’s multibrand portfolio, and manage R&D efforts under the Company’s wholly owned biotechnology subsidiary, TruLife Biotech. She will also lead collaborative partnerships with research centers and academic institutions and drive sustainable growth by guiding the Company across the global regulatory landscape.  

After obtaining her master’s degree in Industrial Chemistry from the University of Rome, La Sapienza and a Ph.D. in Material Engineering from the University of Rome, Tor Vergata, Dr. Serraino Fiory began her career in the pharmaceutical industry. Starting in Regulatory and Medical Affairs at Pfizer, she then took on the role of head of Regulatory and Medical Affairs at Johnson & Johnson Consumer Health Care, Italy. Perrigo Pharma then recruited her to serve as Regulatory, Quality and Medical Affairs director. In this role, Dr. Serraino Fiory oversaw the Italian regulatory medical, quality, pharmacovigilance and legal team of Perrigo Pharma Italia. She also led the Italian affiliate’s portfolio, which included medicinal products, cosmetic products, medical devices, food supplements, biocides and veterinary products. During a career that spanned two decades of side-by-side work with European Health Authorities and the FDA, she developed a keen knowledge of the pharmaceutical environment, medicinal products, herbals, medical devices, cosmetics and food supplements.

Dr. Serraino Fiory is also a Certified Nutritional Consultant, Clinical Master Herbalist, Clinical Aromatherapist and Certified Holistic Health Practitioner in Traditional Chinese Medicine. She is currently attending the DACM program at Pacific College of Health and Science in San Diego to become a Doctor in Acupuncture and Chinese Medicine. Her firsthand and inside experience with both Eastern and Western Medicine has led her to cultivate a 360-degree perspective on the best practices for achieving and maintaining optimum health.

About Green Hygienics Holdings Inc.

Green Hygienic Holdings Inc. (OTCQB: GRYN) (“Green Hygienics” or the “Company”) is a California-based innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The Company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies.

Hygienics is the science of preserving and promoting the health of individuals, communities and the planet.

For further information about Green Hygienics Holdings Inc., please visit the Company’s website at:  http://www.greenhygienics.com/

Follow us on  Facebook, Twitter, Instagram and Linkedin.

Corporate Communications:
Heidi Thomasen
IR@GreenHygienics.com
Toll Free 1.855.802.0299

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

This document contains forward-looking statements. In evaluating these forward-looking statements, you should consider various factors, including our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.

Public Relations:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

FAQ

Who is the new Chief Scientific Officer of Green Hygienics Holdings Inc. (GRYN)?

Dr. Francesca Serraino Fiory has been appointed as the new Chief Scientific Officer.

What is Dr. Francesca Serraino Fiory's background?

She has worked in regulatory and medical affairs for major pharmaceutical companies, including Pfizer and Johnson & Johnson.

What are Dr. Serraino Fiory's responsibilities at Green Hygienics Holdings Inc.?

She will oversee product development, R&D efforts, and manage partnerships with research institutions.

How will Dr. Serraino Fiory contribute to Green Hygienics Holdings Inc. (GRYN)?

Her role is expected to drive sustainable growth and navigate the global regulatory landscape.

What is the focus of Green Hygienics Holdings Inc. (GRYN)?

The company specializes in cultivating industrial hemp and producing pharmaceutical-grade bioactive cannabinoids.